title: [Clinical practice guidelines: 2006 update of recommendations for the radiotherapeutic management of patients with soft tissue sarcoma (sarcoma of the extremity, uterine sarcoma and retroperitoneal sarcoma].
abstract: BACKGROUND
  The National French Federation of Comprehensive Cancer Centres (FNCLCC) initiated the update of clinical practice guideline for the management of patients with soft tissue sarcoma in collaboration with the French Sarcoma Group (GSF-GETO), specialists from French public universities, general hospitals and private clinics and with the French National Cancer Institute. This work is based on the methodology developed in the "Standards, Options and Recommendations" (SOR) project.
  
  
  OBJECTIVE
  To update SOR guidelines for the management of patients with soft tissue sarcoma previously validated in 1995.
  
  
  METHODS
  The methodology is based on a literature review and critical appraisal by a multidisciplinary group of experts who define the CPGsaccording to the definitions of the Standards, Options and Recommendations project. Once the guidelines have been developed, they are reviewed by independent reviewers.
  
  
  RESULTS
  This article presents the updated recommendations for radiotherapeutic management. The main recommendations are: 1) irradiation before or after surgical treatment is the standard for soft tissue sarcoma of the extremity and uterine sarcoma; 2) no systematic irradiation should be done in case of retroperitoneal sarcoma.
authors.affiliation: Institut Gustave-Roussy, Villejuif, France.
authors.forename: C
authors.initials: C
authors.lastname: Le Péchoux
authors.forename: P
authors.initials: P
authors.lastname: Pautier
authors.forename: M
authors.initials: M
authors.lastname: Delannes
authors.forename: B N
authors.initials: BN
authors.lastname: Bui
authors.forename: F
authors.initials: F
authors.lastname: Bonichon
authors.forename: S
authors.initials: S
authors.lastname: Bonvalot
authors.forename: A
authors.initials: A
authors.lastname: Chevalier-Place
authors.forename: J-M
authors.initials: JM
authors.lastname: Coindre
authors.forename: A
authors.initials: A
authors.lastname: Le Cesne
authors.forename: P
authors.initials: P
authors.lastname: Morice
authors.forename: I
authors.initials: I
authors.lastname: Ray-Coquard
authors.forename: E
authors.initials: E
authors.lastname: Stöeckle
authors.forename: S
authors.initials: S
authors.lastname: Taieb
mesh_terms: D001918:Brachytherapy; D005260:Female; D005602:France; D006801:Humans; D035002:Lower Extremity / Q000528:radiation effects* / Q000601:surgery; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D012186:Retroperitoneal Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D012509:Sarcoma / Q000532:radiotherapy* / Q000601:surgery; D012983:Soft Tissue Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D034941:Upper Extremity / Q000528:radiation effects* / Q000601:surgery; D014594:Uterine Neoplasms / Q000532:radiotherapy* / Q000601:surgery